Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02536794
Title MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.